



Introductıon: We evaluated the eff ect of diff erent syringe volume, needle size and sample volume on blood gas analysis in syringes washed with 
heparin.
Materials and methods: In this multi-step experimental study, percent dilution ratios (PDRs) and fi nal heparin concentrations (FHCs) were calcu-
lated by gravimetric method for determining the eff ect of syringe volume (1, 2, 5 and 10 mL), needle size (20, 21, 22, 25 and 26 G) and sample volu-
me (0.5, 1, 2, 5 and 10 mL). The eff ect of diff erent PDRs and FHCs on blood gas and electrolyte parameters were determined. The erroneous results 
from nonstandardized sampling were evaluated according to RiliBAK’s TEa.
Results: The increase of PDRs and FHCs was associated with the decrease of syringe volume, the increase of needle size and the decrease of sample 
volume: from 2.0% and 100 IU/mL in 10 mL-syringe to 7.0% and 351 IU/mL in 1 mL-syringe; from 4.9% and 245 IU/mL in 26G to 7.6% and 380 IU/mL 
in 20 G with combined 1 mL syringe; from 2.0% and 100 IU/mL in full-fi lled sample to 34% and 1675 IU/mL in 0.5 mL suctioned sample into 10 mL-
syringe. There was no statistical diff erence in pH; but the percent decreasing in pCO2, K
+, iCa2+, iMg2+; the percent increasing in pO2 and Na
+ were 
statistical signifi cance compared to samples full-fi lled in syringes. The all changes in pH and pO2 were acceptable; but the changes in pCO2, Na
+, K+ 
and iCa2+ were unacceptable according to TEa limits except fullfi lled-syringes.
Conclusions: The changes in PDRs and FHCs due nonstandardized sampling in syringe washed with liquid heparin give rise to erroneous test results 
for pCO2 and electrolytes.
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Fifty years ago, some researchers fi rst reported 
that collection of blood gas samples into the sy-
ringe with liquid heparin caused dilutional error 
(1-3). But, heparinized blood collection for blood 
gas analysis in some clinics or hospitals is still pre-
ferred in plastic syringes with liquid heparin in-
stead of syringes with dry heparin due to econom-
ical and traditional reasons.
Some researchers notifi ed recommendations 
about standardized blood collection into syringes 
washed with liquid heparin (4,5). Also, Internation-
al Federation of Clinical Chemistry (IFCC) recom-
mended for blood gas sampling to fi ll dead space 
of the syringe with heparin, to lubricate the inner 
wall of the syringe, to expel the excess anticoagu-
lant and to collect the least 20 times the dead 
space volume of blood (6). Clinical and Laboratory 
Standards Institute (CLSI) and American Associa-
tion for Respiratory Care (AARC) published the 
guidelines for blood gas analysis which were not 
described the blood collecting procedure in sy-
ringes washed with liquid heparin, but they 
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warned the combine eff ects from together dilu-
tional and chemical eff ects of liquid heparin to 
blood gas tests (7,8).
Despite all these publications, we have frequently 
observed the nonstandardized blood gas sam-
pling with liquid heparin (especially using diff erent 
volumes syringes, diff erent sizes needles and col-
lecting diff erent sample volume) is used for pa-
tient’s comfort, easier application or ignorance 
about the eff ects. For these reasons, in this study, 
we evaluated the eff ect of i) dilution rates of dis-
posable plastic syringes and needles; ii) fi nal hepa-
rin concentrations; and iii) non-standardized sam-
pling volume on blood gas parameters sampled in 




Four diff erent volumes of disposable plastic sy-
ringes (1, 2, 5 and 10 mL) (Hayat Medical Device 
Inc, Istanbul, Turkey) and fi ve diff erent sizes of dis-
posable needles (Gauge: diameter x length, 20G: 
0.90 x 38 mm, 21G: 0.80 x 38 mm, 22G: 0.70 x 32 
mm, 25G: 0.50 x 26 mm, 26G: 0.45 x 13 mm) (Hayat 
Medical Device Inc, Istanbul, Turkey) which are fre-
quently found and used in clinics or hospitals, 
were used in this study. Syringes and needles were 
weighed with “Precisa XB 220A” precision balance 
(Precisa Gravimetrics AG, Dietikon, Switzerland) 
which has a capacity of 320 g, a readability of 
0.0001 g, a repeatability of 0.1 g, a linearity of 0.2 g 
and an auto calibration facility. Syringes were 
washed by “Nevparin fl akon” sodium heparin solu-
tion (Mustafa Nevzat İlaç Sanayi AŞ, İstanbul, Tur-
key) which contains 5000 IU/mL heparin.
After the approval of the Ethical Comittee (Dokuz 
Eylul University Medical Faculty, Izmir, Turkey), the 
informed consent was obtained and samples were 
taken from seven healthy volunteers. Blood sam-
ples were collected by venous puncture into previ-
ously heparinized 50 mL-syringes (Hayat Medical 
Device Inc, Istanbul, Turkey). The heparinized sy-
ringes containing approximately 10 IU/mL heparin 
were prepared via injection 0.10 mL of 5000 IU/mL 
sodium heparin solution in 1 mL-syringe from the 
open end of 50 mL-syringes.
The blood gas [pH, partial pressure of carbon diox-
ide (pCO2), partial pressure of oxygen (pO2)] and 
electrolytes [sodium (Na+), potassium (K+), ionized 
calcium (iCa2+), ionized magnesium (iMg2+)] pa-
rameters were analyzed by two identical analyzers 
Nova Critical Care Xpress (Nova Biomedical Corpo-
ration, Waltham, MA, USA) according to manufac-
turer’s instructions. On-board tri-level auto QC 
packs (PN 35625-30, Nova Biomedical Corporation, 
Waltham, MA, USA) were automatically analyzed 3 
times a day for quality control on the Nova system.
Study design
This multi-step experimental study was performed 
between June and August 2011 in the Central Lab-
oratory of Dokuz Eylül University Hospital (Izmir, 
Turkey).
Step 1: Determining the eff ect of syringe volume and 
needle size on percent dilution ratios (PDRs) and 
fi nal heparin concentrations (FHCs):
The PDRs and FHCs in diff erent volumes syringes 
and diff erent sizes needles were calculated from 
the dead space and total capacity for each materi-
al. Diff erent volumes disposable plastic syringes 
with attached needles (1, 2, 5 and 10 mL) and dif-
ferent sizes needles with attached tips (20, 21, 22, 
25 and 26G) were weighed 10 times. For suction-
ing and dispensing pure water, the needles were 
combined with 1 mL-syringes. Then, the needles 
were weighed without syringes. The balance was 
zeroed before each measurement. The measure-
ments and calculations performed are described 
below.
Descriptions of weights:
Empty weight; newly unpacked empty syringes • 
attached with needles and needles attached 
with tips were weighed.
Full-fi lled weight; syringes and needles which • 
were fi lled with pure water to total capacity 
were weighed.
Washed weight; syringes were weighed after • 
applying standardized washing with pure wa-
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ter. For standardized washing, syringes were 
washed consecutively 2 times by fi lling to total 
capacity graduation lines and then emptying to 
zero graduation lines with pure water.
Descriptions of calculations:
Dead space (DS); is the remaining amount of • 
pure water in syringes which were fi lled with 
pure water and then emptied, in needles which 
were only fi lled with pure water, it was calculat-
ed via formula below:
For syringes; Weight of dead space (g) =  
Washed weight (g) - Empty weight (g);
For needles; Weight of dead space (g) = Full- 
fi lled weight (g) - Empty weight (g);
Volume of dead space (mL) = Mass of dead  
space (g) x Z factor (mL/g). Z factor is a cor-
rection factor in the volumetric calculations 
to compensate for the density of the water at 
the test conditions. To fi nd the Z factor, Z fac-
tor chart were used according to tempera-
ture (on row) and barometric pressure (on 
column) measured during the test (9).
Total capacity (TC); is the amount of suctioned • 
pure water into syringes, it was calculated via 
formula below:
Weight of total capacity (g) = Full-fi lled  
weight (g) – Empty weight (g);
Volume of total capacity (mL) = Mass of total  
capacity (g) x Z factor (mL/g).
Percent dilution ratio (PDR); is the percent ratio • 
of liquid volumes retain in dead space of sy-
ringes or needles to volumes of total capacity 
of syringes, is the amount of dilution error, it 
was calculated via formula below:
Percent dilution ratio (%) = (Volume of dead  
space (mL) / Volume of total capacity (mL)) x 
100.
Final heparin concentration (FHC); is the amount • 
of heparin in sample which suctioned to syring-
es washed with liquid heparin, is the amount of 
chemical error, it was calculated via formula be-
low:
Final heparin concentration (IU/mL) =  
(Heparin volume (mL) / Volume of total ca-
pacity (mL)) x Heparin concentration used 
(5000 IU/mL). Heparin volume is an amount 
of the remaining heparin volume in dead vol-
ume of syringes. Volume of total capacity is 
the amount of suctioned pure water or sam-
ple volume into syringes.
Percent of total dead space (PTDS): is the per-• 
cent ratio of dead space of needles to total dead 
space of syringes. It was calculated using for-
mula below:
Percent total dead space (PTDS) (%) = (Vol- 
ume of dead space of needle (mL) / Volume 
of total dead space of syringe (mL)) x 100.
Step 2: Determining the eff ect of sample volume size 
on PDRs and FHCs:
After all syringes were washed, 0.5 mL and 1 mL of 
pure water were suctioned into 1 mL- syringes; 0.5 
mL, 1 mL and 2 mL into 2 mL- syringes; 0.5 mL, 1 
mL, 2 mL and 5 mL into 5 mL- syringes; 0.5 mL, 1 
mL, 2 mL, 5 mL and 10 mL into 10 mL- syringes for 
determining the eff ect of nonstandardized sam-
pling size that is less than the full volume sampling 
on dilutional and chemical error. Filled and emp-
tied syringes with attached needles were weighed. 
Total capacities of syringes, PDRs and FHCs in sy-
ringes were calculated.
Step 3: Determining the eff ect of diff erent PDRs and 
FHCs on blood gas and electrolyte parameters:
50 mL venous blood samples in previously hepa-
rinized syringes were obtained from 7 volunteers. 
Whole blood samples obtained from each volun-
teer were suctioned into 10 mL-syringes previously 
washed with liquid heparin, in volumes of 0.5 mL, 
1 mL, 2 mL, 5 mL and 10 mL. Because of all sam-
ples analysis fi nished in > 30 minutes, the samples 
(50-mL whole blood and 10-mL experimental ali-
quots) were kept on ice until the analysis and the 
samples were remixed by inverting and rolling 
horizontally before analysis. Baseline whole blood 
sample aliquots suctioned into empty syringes 
with no additive and no washed were analyzed for 
comparison before each set. The error of baseline 
samples which have approximately 10 IU/mL of 
FHC (and 0.2% of PDR) was neglected. Each aliquot 
set was analyzed for blood gas parameters as soon 
as possible within themselves (within 5-10 min-
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utes). Then, the changes and the percent changes 
from baseline were calculated for each parameter. 
They were calculated via formula below:
Change in test result = Experiment sample  
test result - Baseline sample test result.
Percent change in test result (%) = (Change in  
test result / Baseline sample test result) x 
100.
These steps are presented in a fl owchart in Figure 1.
Step 4: Determining the erroneous results due to 
the nonstandardized sampling size in random 
clinical samples according to the German Medical 
Association Directive on Quality Assurance of 
Quantitative Laboratory Tests for Medical Purposes 
(RiliBAK)’s Allowable Total Error (TEa):
According to six-month data, on average 3109 
blood gas samples per month are analyzed on two 
blood gas devices in Central Laboratory of Dokuz 
Eylul University Hospital. The samples which have 
< 0.5 mL for 10 mL-syringes and < 0.2 mL for other 
syringes of sampling size are rejected because of 
blood gas device warns “no sample error” alarm. 
The distribution of samples according to sampling 
size were determined from the consecutive 100-
routine blood gas samples at working hours in last 
2 days to our laboratory. Then the bias (%) of rou-
tine blood gas results according to PDRs and FHCs 
from nonstandardized sampling size were com-
pared according to the RiliBAK’s TEa. The total al-
lowable limits of RiliBAK are 0.06 for pH, 12% for 
pCO2, 12% for pO2, 5% for Na+, 9.1% for K+, 15% for 
Ca2+ (10).
Analytical validation of experimental methodology
Gravimetric measurements
To validate the methodology in experimental 
methods used in this study, 0.1 mL and 1 mL of 
pure water were suctioned by calibrated micropi-
pettes and then weighed 20 times. Micropipets 
were calibrated with a diff erent precision balance 
by a commercial calibration laboratory (Omega 
Kalibrasyon Merkezi, İzmir, Turkey) which is accred-
ited according to ISO/EIC 17025 by Turkish Accredi-
tation Agency (TURKAK). Then CV% ((SD/Mean) x 
100), bias% ([(Measured value – True value) / True 
value] x 100) and total error (Bias% + (1.65 x CV%)) 
were calculated. CV% were 0.81% and 0.16%, bias% 
were 0.60% and 0.30%, total error were 2.19% and 
0.58% for 0.1 mL and 1 mL volumes, respectively.
The same measurements were repeated by using 
heparin. Then densities of water and heparin were 
calculated as 0.995 g/mL and 1.025 g/mL for 1 mL 
volumes, respectively. The density diff erence be-
FIGURE 1. Flowchart of the Step 3.
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tween heparin and pure water was calculated as 
3.1%. Considering that this diff erence in density is 
too small to cause any diff erence in attachment to 
inner surface of syringes and needles between 
heparin and water, thus pure water was used in-
stead of heparin for dead space determination.
Blood gas measurements
The pH, pCO2, Na+, K+, iCa2+, iMg2+ were measured 
by ion selective electrode potentiometry, and pO2 
was measured by amperometry on blood gas ana-
lyzer. The method validations of tests done accord-
ing to the requirements of the ISO 15189:2007 (11). 
Coeffi  cient variation (CV) (%) and bias (%) of tests 
were determined, and then total errors (TE) of tests 
were calculated by “TE = bias (%) + 1.65 CV (%)” 
formula. Tests were validated, if total errors of tests 
were lower than the RiliBAK TEa (10).
Statistical analysis
The distribution of the variables was determined 
using Kolmogorov-Smirnov test. In normally dis-
tributed groups the results were presented with 
mean and SD. The signifi cance of the changes in 
blood gas and electrolyte parameters at diff erent 
PDRs and FHCs compared with PDRs and FHCs of 
full-fi lled syringes were analyzed by one-way ANO-
VA using PASW Statistics or Windows 18.0 (IBM 
Corporation, NY, US). Post hoc analysis was per-
formed by Bonferroni posthoc test because of test-
ing the complex pairs and reducing the probabili-
ty of a Type I error (12). P value < 0.05 was consid-
ered signifi cant.
Results
The eff ect of syringe volume and needle size 
on PDRs and FHCs
The dead spaces were determined as 0.203 mL in 
10 mL-, 0.148 mL in 5 mL-, 0.097 mL in 2 mL-, 0.076 
mL in 1 mL-syringes. We determined PDRs and 
FHCs of 1 mL, 2 mL, 5 mL, 10 mL volumes syringes 
were 7.0%, 4.6%, 2.9%, 2.0% and 351 IU/mL, 230 IU/
mL, 144 IU/mL, 100 IU/mL, respectively (Table 1).
The dead spaces were determined as 0.061 mL in 
20G-, 0.054 mL in 21G-, 0.049 mL in 22G-, 0.046 mL 
in 25G-, 0.026 mL in 26G-needles. The dead spaces 
of 20G-, 21G-, 22G-, 25G- needles for 1 mL-syringe 
and 20G-, 21G-, 22G-needles for 2 mL-syringe were 
determined to consist more than 50% of total dead 
volume. The PDRs and FHCs of diff erent sizes nee-
dles with attached tips were shown in Table 2.
The eff ect of sample volume size on PDRs and 
FHCs
The PDRs and FHCs from diff erent sample volume 
size are shown in Table 3.
Descriptions









Empty weights (g) 2.955 ± 0.019 3.959 ± 0.019 5.291 ± 0.035 8.123 ± 0.074
Full-fi lled weights (g) 4.035 ± 0.019 6.061 ± 0.022 10.422 ± 0.044 18.197 ± 0.107
Washed weights (g) 3.030 ± 0.022 4.056 ± 0.022 5.438 ± 0.039 8.325 ± 0.077
Weights of DS (g) 0.075 ± 0.006 0.097 ± 0.005 0.147 ± 0.010 0.202 ± 0.019
Volumes of DS (mL) 0.076 ± 0.006 0.097 ± 0.005 0.148 ± 0.010 0.203 ± 0.019
Weights of TC (g) 1.080 ± 0.009 2.102 ± 0.007 5.131 ± 0.041 10.074 ± 0.056
Volumes of TC (mL) 1.084 ± 0.009 2.109 ± 0.007 5.147 ± 0.041 10.106 ± 0.056
PDR of full-fi lled syringe (% v/v) 7.0 ± 0.5 4.6 ± 0.2 2.9 ± 0.2 2.0 ± 0.2
FHC of full-fi lled syringe (IU/mL) 351 ± 27 230 ± 11 144 ± 10 100 ± 10
DS - dead space; FHC - fi nal heparin concentration; PDR - percent dilution ratio; TC - total capacity. All results were presented as means ± 
SD. Syringes were measured at 21.5 °C and 101.33 kPa. Z factor is 1.0032 at test conditions.
TABLE 1. The percent dilution ratios and fi nal heparin concentrations from diff erent volumes syringes with attached needles.
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Descriptions
Needles with attached tips
26 Gauge
(0.45 x 13 mm)
(N = 10)
25 Gauge
(0.50 x 26 mm)
(N = 10)
22 Gauge
(0.70 x 32 mm)
(N = 10)
21 Gauge
(0.80 x 38 mm)
(N = 10)
20 Gauge
(0.90 x 38 mm)
(N = 10)
Empty weights (g) 0.656 ± 0.006 0.857 ± 0.005 0.881 ± 0.004 0.941 ± 0.006 0.955 ± 0.022
Full-fi lled weights (g) 0.686 ± 0.009 0.903 ± 0.010 0.930 ± 0.004 0.995 ± 0.007 1.016 ± 0.018
Weights of DS (g) 0.030 ± 0.009 0.046 ± 0.007 0.049 ± 0.002 0.054 ± 0.004 0.061 ± 0.017
Volumes of DS (mL) 0.030 ± 0.009 0.046 ± 0.007 0.049 ± 0.002 0.054 ± 0.004 0.061 ± 0.017
PTDS in 1 mL syringe (% v/v) 40 ± 12 61 ± 7.3* 65 ± 7.0* 71 ± 9.2* 80 ± 24*
PTDS in 2 mL syringe (% v/v) 31 ± 9.6 47 ± 7.4 51 ± 3.7* 56 ± 4.0* 63 ± 16*
PTDS in 5 mL syringe (% v/v) 20 ± 6.1 31 ± 5.6 33 ± 2.2 37 ± 3.6 41 ± 11.0
PTDS in 10 mL syringe (% v/v) 15 ± 4.8 23 ± 3.6 24 ± 2.2 27 ± 1.8 30 ± 9.0
PDR of 1 mL full-fi lled syringe (% v/v) 4.9 ± 0.53 6.3 ± 0.44 6.6 ± 0.49 7.0 ± 0.5 7.6 ± 1.0
PDR of 2 mL full-fi lled syringe (% v/v) 3.5 ± 0.45 4.2 ± 0.36 4.4 ± 0.19 4.6 ± 0.2 4.9 ± 0.7
PDR of 5 mL full-fi lled syringe (% v/v) 2.4 ± 0.41 2.7 ± 0.36 2.8 ± 0.14 2.9 ± 0.2 3.0 ± 0.7
PDR of 10 mL full-fi lled syringe (% v/v) 1.8 ± 0.19 1.9 ± 0.20 2.0 ± 0.19 2.0 ± 0.2 2.1 ± 0.2
FHC of 1 mL full-fi lled syringe (IU/mL) 245 ± 26 316 ± 22 329 ± 24 351 ± 27 380 ± 52
FHC of 2 mL full-fi lled syringe (IU/mL) 175 ± 23 212 ± 18 219 ± 9 230 ± 11 246 ± 36
FHC of 5 mL full-fi lled syringe (IU/mL) 121 ± 21 136 ± 18 139 ± 7 144 ± 10 150 ± 33
FHC of 10 mL full-fi lled syringe (IU/mL) 89 ± 10 97 ± 10 98 ± 10 100 ± 10 104 ± 9
DS - dead space; FHC - fi nal heparin concentration; PDR - percent dilution ratio; PTDS - Percent of total dead space. All needle sizes were presented 
as Gauge (diameter x length). All results were presented as means ± SD. Needles were measured at 21.5 °C and 101.3 kPa. Z factor is 1.0032 at test 
conditions.
*Percent of dead space in syringe >50%.
TABLE 2. The dead spaces, percent dilution ratios and fi nal heparin concentrations in diff erent sizes needles.
TABLE 3. The percent dilution ratios and fi nal heparin concentrations from diff erent sample volume size in diff erent syringes.
Syringes with attached needles
Theoretical
capacity 1 mL 2 mL 5 mL 10 mL
Dead spaces
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TABLE 3. The percent dilution ratios and fi nal heparin concentrations from diff erent sample volume size in diff erent syringes.
Syringes with attached needles
Theoretical
capacity 1 mL 2 mL 5 mL 10 mL
Dead spaces




























































FHC - fi nal heparin concentration; PDR - percent dilution ratios; TC - total capacity. All results were presented as means ± SD. Syringes were 
measured at 221.5 °C and 101.3 kPa. Z factor is 1.0032 at test conditions. 
The eff ect of diff erent PDRs and FHCs on blood 
gas and electrolyte parameters
There was no statistical diff erence in changes of 
pH (P = 0.128); but the percent changes of pO2, 
pCO2, Na+, K+, iCa2+, iMg2+ were signifi cantly diff er-
ent between all groups (P < 0.001). Post hoc analy-
sis showed that samples in full-fi lled syringes were 
signifi cantly diff erent than 2 mL, 1 mL, 0.5 mL sam-
ple volume for all parameters (P < 0.019, P < 0.001, 
P < 0.001 for Na+; P < 0.001, P < 0.001, P < 0.001 for 
K+; P < 0.001, P < 0.001, P < 0.001 for iCa2+; P < 0.001, 
P < 0.001, P < 0.001 for iMg2+, respectively) except 
pCO2, pO2 which were signifi cant in 1 and 0.5 mL 
sample volume (P < 0.001, P < 0.001 for pCO2, and 
P = 0.010, P < 0.001 for pO2, respectively).
The changes and percent changes for each blood 
gas parameter with respect to PDRs and FHCs in 
comparison to acceptable limits for TEa are shown 
in Figure 2. The all changes in pH and percent 
changes in pO2 were acceptable; but the percent 
changes in PDRs and FHCs of 1 mL, 0.5 mL sample 
volume of pCO2; PDRs and FHCs of 2 mL, 1 mL, 0.5 
mL sample volume of Na+; PDRs and FHCs of 2 mL, 
1 mL, 0.5 mL sample volume of K+; PDRs and FHCs 
of 5 mL, 2 mL, 1 mL, 0.5 mL sample volume of iCa2+ 
were unacceptable according to TEa limits of Rili-
BAK (10).
The erroneous results due to the
nonstandardized sampling size in random
clinical samples according to RiliBAK’s TEa
In our laboratory, the 39% of blood gas samples 
were received from emergency department, 25% 
from pediatrics, 17% from chest disease depart-
ments, 16% from internal medicine and 3% from 
surgical departments. The 73% samples were arte-
rial blood and, 27% were venous blood which is 
preferred for evaluating only acid base status in 
clinics. It was observed that small volume syringes 
for blood gas sampling were used more frequently 
in our hospital (64% with 1 mL-syringes, 29% with 
2 mL-syringes, 5% with 5 mL-syringes and 2% with 
10 mL-syringes), and the syringes were not full-
fi lled up to their capacity. Three insuffi  cient samples 
were rejected. It is indicated in Table 4 that nonstan-
dardized sampling caused error above TEa limits of 
RiliBAK in 47% of pCO2 results, 80% of Na+ results, 
99% of K+ results and 100% of iCa2+ results (10).
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According to RiliBAK’s TEa for each 
parameters According to IFCC recommends
pH and blood gases Electrolytes Dilution ratio Heparin conc.
pH PCO2 PO2 Na+ K+ iCa2+






10.0 (full-fi lled) 0 2.0 100 Ut Ut Ut
9.9- 5.0 0 2.1-3.9 101-199 Ut Ut Ut
4.9-2.0 1 4.0-9.6 200-481 Ua Ua Ut Ut Ut Ut
1.9-1.0 0 9.7-18 482-915 Ua Ua Ua Ut Ut Ut Ut Ut
0.9-0.5 1 18-33 916 -1674 Ua Ua Ua Ua Ut Ut Ut Ut Ut Ut
0.4-0.2 0 ≥34 ≥1675 R R R R R R R R R R R R
<0.2 (insuffi  cient) 0 - - R R R R R R R R R R R R
5
5.0 (full-fi lled) 0 2.9 144 Ut Ut Ut
4.9-2.0 1 3.0-7.0 145-352 Ua Ut Ut Ut Ut
1.9-1.0 3 7.1-12 353-669 Ua Ua Ua Ut Ut Ut Ut Ut
0.9-0.5 1 13-23 670-1195 Ua Ua Ua Ua Ut Ut Ut Ut Ut Ut
0.4-0.2 0 ≥24 ≥1196 Ua Ua Ua Ua Ut Ut Ut Ut Ut Ut
<0.2 (insuffi  cient) 0 - - R R R R R R R R R R R R
2
2.0 (full-fi lled) 0 4.6 230 Ut Ut Ut
1.9-1.0 18 4.7- 8.7 231-441 Ua Ua Ut Ut Ut Ut
0.9-0.5 8 8.8-15 442-799 Ua Ua Ua Ut Ut Ut Ut Ut
0.4-0.2 3 ≥16 ≥800 Ua Ua Ua Ua Ut Ut Ut Ut Ut
<0.2 (insuffi  cient) 1 - - R R R R R R R R R R R R
1
1.0 (full-fi lled) 0 7.0 351 Ut Ut Ut Ut
0.9-0.5 22 7.1-13 352-684 Ua Ua Ua Ut Ut Ut Ut Ut
0.4-0.2 42 ≥14 ≥685 Ua Ua Ua Ua Ut Ut Ut Ut Ut
<0.2 (insuffi  cient) 2 - - R R R R R R R R R R R R
Total* 100 0 47 0 80 99 100 5 83 100 100 100 100
Ua - Unacceptable test results (exceeding TEa); Ut - Untolarable samples (exceeding IFCC recommendations); R - Rejected samples. *Total received sample 
without rejected.
TABLE 4. The erroneous results due to nonstandardized sampling according to RiliBAK’s TEa.
Final Heparin Concentation (IU/mL)
101 199 482 919 1723
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FIGURE 2. The changes in pO2 (C), Na+ (D), K+ (E), iCa+2 (F), iMg+2 
(G) at diff erent percent dilution ratios and fi nal heparin concen-
trations according to experiments with 10 mL syringes. They 
were compared binary with PDRs and FHCs of full-fi lled syring-
es The horizontale dotted line indicates the acceptable limits 
for TEa according to RiliBAK except iMg. *P < 0.05 in post hoc 
comparisons with full sampling in syringes.
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Discussion
Most errors aff ecting laboratory test results occur 
in the preanalytical phase, primarily because of the 
diffi  culty in achieving standardized procedures for 
sample collection. The blood gas collection with 
liquid heparin in point of care or laboratory testing 
is one of the sources of preanalytical errors (13-15).
Using liquid heparin as anticoagulant in blood gas 
collection is caused combined eff ect by dilution 
sourced from liquid form (dilutional eff ect), direct 
binding of cations by heparin (chemical eff ect) and 
contamination with type of heparin salt (we named 
as compositional eff ect) were notifi ed by guide-
lines (7,8). In this study, we used two markers for 
determining two major eff ects of liquid heparin: 
percent dilution ratio is abbreviated PDR for dilu-
tional eff ect and fi nal heparin concentration is ab-
breviated FHC for chemical eff ect. These markers 
are depended directly on the amount of heparin 
solution retained in dead space of syringes and 
needles.
Dead space of syringes is defi ned as the volume of 
liquid retained in the hub and needle when the sy-
ringe is completely emptied (16). Hansen et al., 
Hamilton et al. and Bloom et al. measured dead 
spaces of syringes as 0.09 mL in 1 mL-, 0.20 mL in 5 
mL-, 0.25 mL in 10 mL-syringes (3); 0.21 mL in 5 mL-
syringes (4); 0.19 mL in 5 mL-, 0.24 mL in 10 mL-sy-
ringes (17), respectively. However, in our research 
we have obtained smaller dead spaces. This diff er-
ence may be related to the kind of the material the 
syringes are made of, glass or plastic; as well as the 
production technique, raw materials, quality of 
production which all may aff ect the dead spaces 
in the syringes. But, the accuracy of measurement 
system, temperature and other environmental 
conditions are more important. So, we used a pre-
cision balance for measurements (we expressed 
weights and volumes with three decimals) and Z 
factor which is a correction factor in the volumet-
ric calculations to compensate for the density of 
the water at the test conditions.
The dead spaces of syringes were found to in-
crease while the PDRs were found to decrease 
from small volume syringes to large volume sy-
ringes. Usage of small volume syringes can give 
rise to increased PDRs. Also, FHCs increase if small 
volume syringes are used. Consequently, the FHCs 
increase as PDRs increase in syringes.
The dead spaces of needles consist of an impor-
tant part of total dead space of syringes, especially 
in 1 mL- and 2 mL- syringes. Nonstandardized ap-
plication, for example changing syringe needles, 
also contributes to increased PDRs. The PDRs and 
FHCs increase, ranging from 4.9% and 245 IU/mL 
in smallest size (26 G) to 7.6% and 380 IU/mL in 
largest size (20 G) needles combined with 1 mL-sy-
ringe. In daily practice, this nonstandardized appli-
cation is not a problem because usually the nee-
dles in the syringe packages are used or smallest 
size needles are preferred to cause less pain and 
technically easier to use.
Hamilton et al. and Ordog et al. recommended 
standardized blood collection into syringes 
washed with liquid heparin, since the FHC in sy-
ringes washed with liquid heparin is considered to 
be suffi  cient (4,5); IFCC recommends that FHC 
should be equal to 4-6 IU/mL liquid heparin in 
plastic syringes (6). We determined that even with 
standardized washing procedure FHCs in full-fi lled 
syringes were 100-351 IU/mL for all diff erent vol-
umes; this amount is more than enough for antico-
agulation. But, we determined that changes of 
blood gas results in pH, pCO2, pO2, Na+, K+, iCa2+ 
were acceptable according to TEa limits of RiliBAK, 
if samples collect full-fi lled in syringes (10).
Correct heparin concentrations in blood gas sam-
ples are important for anticoagulation. Due to in-
suffi  cient coagulation blood clots occur and cause 
incorrect test results or analyzer failure via obstruc-
tion of tubings. In clinics, in order to avoid insuffi  -
cient coagulation they add more heparin to the sy-
ringes. We determined that PDRs increased 3-53% 
and FHCs increased 151-2669 IU/mL when adding 
heparin to dead spaces of full-fi lled syringes (data 
were not shown). It is evident that added liquid 
heparin will increase the dilutional and chemical 
error.
Hamilton et al. reported that inexperienced resi-
dent staff  sampled large volume heparin and small 
volume blood, then technicians accepted to ana-
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lyze small volume samples if the volume was 
greater than the minimum amount required for 
the analyzer (4). Hutchison et al. reported heparin 
solution is added to a syringe before sampling be-
cause of economical reasons (18); the syringe 
washed with liquid heparin for blood gas analysis 
is also still preferred in our hospital because of 
blood gas syringes cost 2-5 times from routine sy-
ringes without additives. Also, nonstandardized 
sampling size that is less than the standard volume 
from total capacity of syringe is used for patient’s 
comfort and for easier application, which is fre-
quently preferred.
But, we determined that nonstandardized sam-
pling size into the syringes changed PDRs and 
FHCs. In the course of this study, we observed that 
small volume syringes were used mostly in our 
hospital and the syringes were not full-fi lled up to 
their capacity. The PDRs were found to increase 
from full volume sampling to smaller volume sam-
pling of syringes. This condition caused a change 
in diluent-sample (liquid heparin-whole blood) ra-
tio. Nonstandardized sampling size that is less than 
the total capacity of syringes contributes to PDRs 
of 2.0-34%. FHCs in nonstandardized sampling size 
with liquid heparin were higher than IFCC recom-
mendations. FHCs were found increase 1.9 times in 
1 mL-, 3.5 times in 2 mL-, 8.3 times in 5 mL-, 17.1 
times in 10 mL- syringes in 0.5 mL sampling com-
pared to full volume sampling. As less sample vol-
umes are drawn into the syringes, the PDR and 
FHCs increase. Also, usually, heparin solutions 
bought commercially have high concentrations. In 
our hospital, 5000 IU/mL heparin used for antico-
agulation treatment is also frequently used in 
blood gas sampling. This condition may increase 
the chemical eff ects of heparin compared to 1000 
IU/mL heparin solutions.
The pCO2 results are lower than acceptable limits 
for TEa as the sample volume is lower and heparin 
concentration is bigger; the reason for this is dilu-
tional eff ect of heparin solution. Also, pO2 results 
are getting higher (although within allowable 
range according to RiliBAK) as the concentration 
of liquid heparin is higher because of two possible 
reasons: heparin solution itself has pO2 of approxi-
mately 20 kPa and in this study we kept samples 
cooled until analysis which can cause falsely high-
er values of pO2. Problem with Na+ values is con-
nected with usage of liquid Na+ salt of heparin as 
anticoagulant (compositional eff ect) - as the per-
cent of heparin is higher, Na+ value is more falsely 
elevated. Because of ability of heparin molecule to 
bind electrolytes (chemical eff ect), values of iCa2+, 
K+ and iMg2+ are more (falsely) lower as the con-
centration (percentage) of liquid heparin is higher.
In our hospital, blood gas sampling is done most 
frequently with small volume syringes while sam-
pling size is nonstandardized and less than the full 
volume capacity of the syringe. A dramatic result 
of this nonstandardized technique is that 47% of 
pCO2 results, 80% of Na+ results and nearly 100% 
of K+ and iCa2+ results are found to contain error 
above the TEa according to RiliBAK (10).
The calculated percent changes of pCO2 and elec-
trolyte results due to nonstandardized sampling in 
patient samples were found to exceed the accept-
able error rates in PDR considered untolerable by 
IFCC. IFCC declares that the eff ects up to 10% dilu-
tion on blood gases results and up to 5% on elec-
trolytes results are tolerable for most practical pur-
poses (6). Also, IFCC declares that ionized calcium 
and magnesium measurements are aff ected by 
FHCs of samples which should not be higher than 
15 IU/mL in tubes, 40 IU/mL in syringes and 50 IU/
mL in capillary tubes (19,20). Considering IFCC rec-
ommendations about the PDRs and FHCs, it was 
observed that 83% of blood gas results and 100% 
of blood electrolytes results were aff ected from 
high PDR and 100% of blood electrolytes results 
were aff ected from high heparin concentrations.
In conclusion, the present study demonstrates that 
the nonconformities in sampling for blood gas 
analysis are causing unacceptable test results for 
pCO2 and electrolytes. The danger from nonstan-
dardized blood collection into the syringe washed 
with liquid heparin should be careful assessed. For 
preventing serious medical errors due to nonstan-
dardized blood gas sampling, electrolyte balanced 
dry heparin may be recommended. If not possible, 
standardized techniques which the dead space of 
the syringes only fi lls with heparin and samples 
collect to total capacity of syringe should be used. 
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Also, medical errors due to incorrect test results 
should always be followed by clinical laboratory 
management for laboratory testing and point of 
care comittee for point of care testing. Standard-
ized procedures should be prepared and applied 
along with education of staff  about blood gas 
samples.
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Učinak različitog volumena injekcije, veličine igle i volumena uzorka kod 
analize plinova u krvi primjenom hepariniziranih injekcija
Sažetak
Uvod: Ispitali smo učinak različitih volumena injekcije, veličine igle i volumena uzorka na analizu plinova u krvi primjenom hepariniziranih 
injekcija.
Materijali i metode: U ovom višestupanjskom eksperimentalnom istraživanju gravimetrijskom smo metodom izračunali postotke omjera ra-
zrjeđenja (engl. percent dilution ratios, PDRs) i krajnje koncentracije heparina (engl. fi nal heparin concentrations, FHCs) kako bi odredili učinak 
volumena injekcije (1, 2, 5 i 10mL), veličine igle (20, 21, 22, 25 i 26G) i volumena uzorka (0,5, 1, 2, 5 i 10mL). Određen je učinak različitih PDR i FHC 
na određivanje plinova i elektrolita u krvi. Pogrešni rezultati nestandardiziranog uzorkovanja procijenjeni su prema dozvoljenoj ukupnoj pogreški 
(engl. allowable total error, TEa) iz smjernica za osiguranje kvalitete kvantitativnog laboratorijskog ispitivanja u medicinske svrhe Njemačke liječ-
ničke komore (RiliBAK).
Rezultati: Povišenje PDR i koncentracije FHC povezane su sa smanjenjem volumena injekcije, povećanjem veličine igle te smanjenjem volumena 
uzorka: od 2,0% i 100 lU/mL u injekciji od 10 mL do 7,0% i 351 IU/mL u injekciji od 1 mL; od 4,9% i 245 IU/mL kod veličine igle 26G do 7,6% i 380 
IU/mL kod veličine igle 20 G u kombinaciji s injekcijom od 1 mL; od 2,0% i 100 IU/mL u injekciji popunjenoj uzorkom do 34% i 1675 IU/mL u injek-
ciji od 10 mL s 0,5 mL uvučenog uzorka. Kod određivanja pH nije pronađena statistički značajna razlika, no sniženje PDR kod parametara pCO2, K
+, 
iCa2+, iMg2+ te povišenje PDR kod pO2 i Na
+ bilo je statistički značajno u usporedbi sa slučajevima u kojima su injekcije bile u potpunosti popunje-
ne uzorkom. Sve promijene kod pH i pO2 bile su prihvatljive; međutim promjene kod pCO2, Na
+, K+ i iCa2+ bile su neprihvatljive prema granicama 
ukupne dozvoljene pogreške, osim u slučajevima u kojima su injekcije bile potpunosti popunjene uzorkom.
Zaključak: Nestandardizirano uzorkovanje primjenom injekcija koje sadrže tekući heparin, uslijed kojeg je došlo do promjena u PDR i FHC, uzro-
kuje pogrešne rezultate kod određivanja koncentracije pCO2 i elektrolita.
Ključne riječi: analize plinova u krvi; uzorkovanje krvi; heparin; igle; injekcije
